Bolt Biotherapeutics Inc. (BOLT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Bolt Biotherapeutics Inc.

NASDAQ: BOLT · Real-Time Price · USD
5.31
0.35 (7.06%)
At close: Oct 03, 2025, 3:59 PM
5.31
0.00%
After-hours: Oct 03, 2025, 07:53 PM EDT

Bolt Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.21M 10.81M 9.24M 27.38M
Short-Term Investments
40.12M 91.38M 159.64M 158.84M
Long-Term Investments
22.88M 26.41M 23.94M 85.35M
Other Long-Term Assets
1.04M 3.59M 2.59M 2.61M
Receivables
1.17M n/a n/a n/a
Inventory
n/a n/a -800K -200K
Other Current Assets
1.29M 3.52M 3.86M n/a
Total Current Assets
50.81M 105.71M 172.75M 189.16M
Property-Plant & Equipment
24.89M 24.08M 28.52M 30.6M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
48.82M 54.08M 55.06M 118.56M
Total Assets
99.63M 159.78M 227.81M 307.72M
Account Payables
1.51M 2.99M 3.59M 3.57M
Deferred Revenue
3.02M 2.2M 1.99M 2.87M
Short-Term Debt
n/a n/a 2.39M 2.5M
Other Current Liabilities
9.08M 6.67M 2.41M 5M
Total Current Liabilities
15.86M 20.46M 23.12M 21.33M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 43K 42K 210K
Total Long-Term Liabilities
26.58M 26.59M 33.18M 36.27M
Total Liabilities
42.43M 47.04M 56.3M 57.6M
Total Debt
25.21M 20.22M 22.61M 24.36M
Book Value
57.2M 112.74M 171.51M 250.12M
Book Value Per Share
1.50 2.98 4.59 6.69
Common Stock
n/a 1K n/a n/a
Retained Earnings
-427.4M -364.29M -295.09M -206.99M
Comprehensive Income
97K 37K -919K -321K
Shareholders Equity
57.2M 112.74M 171.51M 250.12M
Total Investments
63M 117.79M 183.59M 244.18M